🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the efficacy, safety, and pharmacokinetics of immu...
Status
Terminated
Location
Comprehensive Cancer Centers of Nevada (CCCN) - Central Valley
Start Date
2017-12-27
Trial ID
NCT03337698
This will be a Phase 1, open-label, randomized, 3-way crossover study to ev...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2017-07-20
Trial ID
NCT03237988
Treatments Being Tested
To learn if the combination of ciforadenant, ipilimumab, and nivolumab can ...
Status
Active Not Recruiting
Location
Duke Cancer Institute
Start Date
2023-02-09
Trial ID
NCT05501054
Treatments Being Tested
This is a Phase 1/1b open-label, dose escalation and dose expansion study o...
Status
Completed
Location
Arizona Oncology
Start Date
2018-04-25
Trial ID
NCT03454451
This is a Phase 1b open-label study of ciforadenant, an oral, small molecul...
Status
Completed
Location
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2020-02-20
Trial ID
NCT04280328
Treatments Being Tested
This is a phase 1/1b open-label, multicenter, dose-selection study of cifor...
Status
Completed
Location
University of Arizona Cancer Center
Start Date
2016-01
Trial ID
NCT02655822
Treatments Being Tested